Beast Ventures

Baseimmune is a biotechnology company developing a platform for analyzing pathogens to create antigen and vaccine designs. Its technology generates antigens using advanced informatics, allowing healthcare providers to maintain vaccine effectiveness against mutating pathogens.

Nutropy produces real milk ingredients identical to those produced by cows, using microbes and fermentation. They develop premium cheese alternatives that offer the same taste as cow's cheese but are more sustainable, healthier, and better for animals.

Baseimmune is a biotechnology company developing a platform for analyzing pathogens to create antigen and vaccine designs. Its technology generates antigens using advanced informatics, allowing healthcare providers to maintain vaccine effectiveness against mutating pathogens.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Clear Labs is a biotechnology company specializing in next-generation sequencing and data analytics for infectious disease surveillance and food safety testing. Its platforms, Clear Dx™ and Clear Safety™, enable rapid identification of pathogens, supporting public health initiatives and enhancing safety across various sectors.

LabGenius Ltd is a biopharmaceutical company based in London, United Kingdom, focused on discovering and developing new protein therapeutics to address unmet medical needs, including conditions like Inflammatory Bowel Disease. Founded in 2012, the company utilizes a machine learning-driven evolution engine and a robotic platform known as EVA, which is capable of designing, conducting, and learning from its own experiments. This innovative approach integrates advanced technologies from synthetic biology, robotics, and machine learning, enabling the engineering of protein drugs with enhanced properties such as protease stability and tissue penetration. By leveraging these cutting-edge methodologies, LabGenius aims to provide physicians with access to novel protein therapeutics that are developed through automation and intelligent design.

Sparrho is a London-based company that operates a discovery platform designed to make scientific information more accessible. Founded in 2013 by two Oxbridge scientists, the platform aggregates, distills, and recommends relevant content from a wide array of scientific sources, including journals, patents, and conference materials. It offers customized, filtered recommendations to users, allowing them to add content and sources, as well as save, share, and disseminate discoveries. By leveraging a unique combination of artificial intelligence and expertise from PhD professionals, Sparrho enhances the literature search experience and caters to a diverse clientele, including Fortune 500 companies around the world. The company was previously known as Epistora.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.